دورية أكاديمية

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial

التفاصيل البيبلوغرافية
العنوان: Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
المؤلفون: de Azambuja, E., Agostinetto, E., Procter, M., Eiger, D., Pondé, N., Guillaume, S., Parlier, D., Lambertini, M., Desmet, A., Caballero, C., Aguila, C., Jerusalem, G., Walshe, J.M., Frank, E., Bines, J., Loibl, S., Piccart-Gebhart, M., Ewer, M.S., Dent, S., Plummer, C., Suter, T.
المصدر: In ESMO Open February 2023 8(1)
قاعدة البيانات: ScienceDirect
الوصف
تدمد:20597029
DOI:10.1016/j.esmoop.2022.100772